The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An amplicon-based liquid biopsy for detecting ALK and ROS1 fusions and resistance mutations in advanced non-small cell lung cancer (NSCLC) patients.
 
Laura Mezquita
No Relationships to Disclose
 
Cecile Jovelet
No Relationships to Disclose
 
Ludovic Lacroix
No Relationships to Disclose
 
David Planchard
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MSD Oncology; Novartis; Pfizer; Roche
 
Gonzalo Recondo
No Relationships to Disclose
 
Emma Pailler
No Relationships to Disclose
 
Edouard Auclin
No Relationships to Disclose
 
Vincent Plagnol
Employment - Inivata
 
Karen Howarth
Employment - Inivata
 
Clive D. Morris
Employment - Inivata
Leadership - Inivata
Stock and Other Ownership Interests - Inivata
 
Emma Green
Employment - Inivata
 
Etienne Rouleau
No Relationships to Disclose
 
Claudio Nicotra
No Relationships to Disclose
 
Caroline Caramella
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer
 
Julien Adam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
Research Funding - MSD (Inst); Pierre Fabre (Inst); Sanofi (Inst)
 
Nathalie Auger
No Relationships to Disclose
 
Francoise Farace
No Relationships to Disclose
 
Luc Friboulet
No Relationships to Disclose
 
Benjamin Besse
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Inivata (Inst); Lilly (Inst); Loxo (Inst); Novartis (Inst); OncoMed (Inst); Onxeo (Inst); ose pharma (Inst); ose pharma (Inst); Pfizer (Inst); Roche/Genentech (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Medarex; Novartis; Pfizer; Pierre Fabre; Roche